Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single‐agent fibroblast growth factor receptor‐specific inhibitors in pancreatic cancer

Documenti analoghi

• Hand–foot skin reaction as a positive prognostic factor in vascular endothelial growth factor receptor‐tyrosine kinase inhibitor treatment
  di: I‐Hsin Huang, et al.
  Pubblicazione: (2026)
• Silibinin, a commonly used therapeutic agent for non‐alcohol fatty liver disease, functions through upregulating intestinal expression of fibroblast growth factor 15/19
  di: Yujie Bai, et al.
  Pubblicazione: (2024)
• Model‐informed dose selection for an investigational human epidermal growth factor receptor 2 antibody–drug conjugate FS‐1502 in patients with human epidermal growth factor receptor 2‐expressing advanced malignant solid tumours
  di: Yi Sun, et al.
  Pubblicazione: (2024)
• A p75 neurotrophin receptor‐sparing nerve growth factor protects retinal ganglion cells from neurodegeneration by targeting microglia
  di: Laura Latini, et al.
  Pubblicazione: (2024)
• Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients
  di: Grace Whelan, et al.
  Pubblicazione: (2026)